Search Results - "MEYERS, C. Daniel"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection by Meyers, C Daniel, Kashyap, Moti L

    Published in Current opinion in cardiology (01-07-2004)
    “…PURPOSE OF REVIEWDespite the best efforts in reduction of low-density lipoprotein cholesterol, most cardiovascular events are not being prevented. Because…”
    Get full text
    Journal Article
  2. 2

    Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL by Meyers, C. Daniel, Tannock, Lisa R., Wight, Thomas N., Chait, Alan

    Published in Journal of lipid research (01-11-2003)
    “…Retention of LDL in the artery intima is mediated by extracellular matrix proteoglycans and plays an important role in the initiation of atherosclerosis…”
    Get full text
    Journal Article
  3. 3

    Niacin therapy in atherosclerosis by Meyers, C Daniel, Kamanna, Vajinath S, Kashyap, Moti L

    Published in Current opinion in lipidology (01-12-2004)
    “…Well designed, randomized, placebo-controlled studies show that niacin prevents cardiovascular disease and death. Unfortunately, early studies and anecdotal…”
    Get full text
    Journal Article
  4. 4

    Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush by Meyers, C. Daniel, Liu, Paul, Kamanna, Vaijinath S, Kashyap, Moti L

    Published in Atherosclerosis (01-06-2007)
    “…Abstract Nicotinic acid is a safe, broad-spectrum lipid agent shown to prevent cardiovascular disease, yet its widespread use is limited by the prostaglandin…”
    Get full text
    Journal Article
  5. 5

    Varying cost and free Nicotinic acid content in over-the-counter niacin preparations for dyslipidemia by MEYERS, C. Daniel, CARR, Molly C, PARK, Sang, BRUNZELL, John D

    Published in Annals of internal medicine (16-12-2003)
    “…Nicotinic acid is an effective treatment for dyslipidemia, but the content of over-the-counter niacin is not federally regulated. As a result, patients may use…”
    Get full text
    Journal Article
  6. 6

    Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapies by Meyers, C Daniel, Kashyap, Moti L

    Published in Current opinion in cardiology (01-07-2005)
    “…PURPOSE OF REVIEWWith the limited effects of low-density lipoprotein-based lipid intervention, more attention is being paid to drugs that augment or mimic…”
    Get full text
    Journal Article
  7. 7

    Management of the metabolic syndrome-nicotinic acid by Meyers, C Daniel, Kashyap, Moti L

    “…Nicotinic acid effectively treats each of the common lipid abnormalities found in the metabolic syndrome, and much progress has recently been made in…”
    Get more information
    Journal Article
  8. 8

    Nicotinic acid induces secretion of prostaglandin D 2 in human macrophages: An in vitro model of the niacin flush by Meyers, C. Daniel, Liu, Paul, Kamanna, Vaijinath S., Kashyap, Moti L.

    Published in Atherosclerosis (2007)
    “…Nicotinic acid is a safe, broad-spectrum lipid agent shown to prevent cardiovascular disease, yet its widespread use is limited by the prostaglandin D 2 (PGD…”
    Get full text
    Journal Article